We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News   Oct 19, 2017 | Original story written by Nathan Collins for Stanford University

 
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

Stanford scientists have developed a synthetic substitute for a drug derived from Bugula neritina, or spiral-tufted bryozoan. (Image credit: Fitzgerald Marine Reserve Docent/Creative Commons)

 
 
 

RELATED ARTICLES

Gene Linked to Impaired Memory in Down Syndrome – A Potential Drug Target?

News

It may one day be possible to reverse abnormal embryonic brain development linked to Down syndrome (DS) and improve cognitive function by therapeutically targeting a key gene known as OLIG2 prenatally, suggests newly published findings.

READ MORE

How to Change the Mind of an Anti-Vaxxer : Study

News

Learning first-hand of the pain and cost of vaccine-preventable diseases moves the needle.

READ MORE

A Possible Reason Why Some Drugs Are Ineffective in Colorectal Cancer

News

A certain group of cancer drugs (MEK Inhibitors) activate the cancer-promoting Wnt signaling pathway in colorectal cancer cells. The findings suggest a possible explanation for why these drugs are not effective in colorectal cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE